Avinger Inc (AVGR) : Kazazian Asset Management added new position in Avinger Inc during the most recent quarter end. The investment management firm now holds 20,000 shares of Avinger Inc which is valued at $85,000 , the company said in a statement filed on Nov 14, 2016 with the SEC.Avinger Inc makes up approximately 0.14% of Kazazian Asset Management’s portfolio.
Other Hedge Funds, Including , Group One Trading sold out all of its stake in AVGR during the most recent quarter. The investment firm sold 600 shares of AVGR which is valued $2,550. Integrated Wealth Counsel added AVGR to its portfolio by purchasing 4,000 company shares during the most recent quarter which is valued at $17,600. Avinger Inc makes up approx 0.04% of Integrated Wealth Counsel’s portfolio.California State Teachers Retirement System boosted its stake in AVGR in the latest quarter, The investment management firm added 15,900 additional shares and now holds a total of 38,809 shares of Avinger Inc which is valued at $170,760. Gilder Gagnon Howe Co sold out all of its stake in AVGR during the most recent quarter. The investment firm sold 82,679 shares of AVGR which is valued $293,510. Nationwide Fund Advisors added AVGR to its portfolio by purchasing 6,716 company shares during the most recent quarter which is valued at $32,371.
Avinger Inc opened for trading at $4.1 and hit $4.15 on the upside on Monday, eventually ending the session at $4.1, with a gain of 1.23% or 0.05 points. The heightened volatility saw the trading volume jump to 99,097 shares. Company has a market cap of $93 M.
Avinger Inc. is a commercial-stage medical device company. The Company designs manufactures and sells image-guided catheter-based systems that are used by physicians to treat patients with peripheral arterial disease (PAD). The Company focuses to introduce products based on its lumivascular platform which is an intravascular image-guided system. The Company manufactures and sells a suite of products in the United States and select European markets. The Company’s products include Lightbox imaging console as well as Wildcat Kittycat and the Ocelot family of catheters which are designed to allow physicians to penetrate a total blockage in an artery known as a chronic total occlusion (CTO). The Company’s lumivascular platform offers real-time visualization of the inside of the artery during PAD treatment.